Human Longevity in it for the long haul, raises $220M Series B
April 07, 2016
Human Longevity has raised a $220 million Series B financing, bringing its total VC funding to $300 million. The company's $80 million Series A round in 2014 valued it at $352 million. Human Longevity is a genomics-based, technology-driven company creating a database of whole genome, phenotype and clinical data.